Electronic Health Records for Dementia Care Research in 2026: A Source-Checked Research Briefing for Adult Children

Learn how clinic records flag hidden dementia risk and what to ask at your parent's next appointment.

Electronic Health Records (EHRs) are the digital charts your parent's clinic keeps for visits, diagnoses, medicines and test results. In 2026, dementia researchers and primary-care teams use those charts to find hidden memory problems earlier and to improve support for families. For adult children, this means a routine visit may prompt follow-up even when no one raised memory concerns. This briefing explains how screening works, what care programs add, and how to respond.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

Table of Contents

Can a routine visit flag hidden memory risk?

Kaiser Permanente Washington and UCSF tested an EHR-based risk score called eRADAR in 11 primary-care clinics. According to the Kaiser Permanente Washington Health Research Institute, half of patients in the top 15% of scores had undiagnosed dementia or mild cognitive impairment, as described in the institute's March research summary.

The score uses information already in the chart, not a new memory test. A high score leads to targeted follow-up, such as a brief cognitive check, review of medicines, and referral when needed.

What help can a Dementia Care Program provide?

The Centers for Medicare and Medicaid Services launched an 8-year GUIDE dementia model on July 1, 2024. According to the agency, 390 organizations are building Dementia Care Programs for hundreds of thousands of beneficiaries, paying for care navigation, caregiver education and respite, as explained in the agency's GUIDE announcement.

For families, the practical link is navigation plus relief. Ask the clinic whether it takes part in a GUIDE program, who serves as the navigator, and how to request caregiver training and short-term respite.

Will a record flag lead to a blood test?

The Food and Drug Administration cleared Fujirebio's Lumipulse G pTau217/B-Amyloid 1-42 plasma-ratio test on May 16, 2025. According to the agency, the test is for adults 55 and older with cognitive symptoms and must be read with history and exams rather than alone, as stated in the FDA clearance announcement.

A chart flag is not a diagnosis. If the clinician suggests this blood test, bring symptom examples, onset dates, medicines, and a family observer, then ask what the result would change.

Why can a chart diagnosis change?

Among 5,965 UCSF Health patients age 50 and older with incident dementia, 13.7% later received a milder MCI diagnosis. According to the Global Brain Health Institute summary of the Alzheimer's and Dementia study, the pattern shows EHR dementia labels can be unstable and need clinical confirmation, as reported in the institute's study summary.

Treat the first label as a working signal. Confirm the exact diagnosis in person, ask which visit and test support it, and request correction if the chart carries forward an old term. Keep a copy of the updated problem list after the visit and share it with every caregiver.

  • Bring two recent examples of memory, language, or daily-task change.
  • List sleep, mood, hearing, and new medicines that can mimic decline.
  • Ask what follow-up test, referral, or recheck date applies.

You Might Also Like

HelpDementia.com

Dementia, Alzheimer's, Caregiving & Healthy Aging Guidance

© 2026 HelpDementia.com. All rights reserved.

Educational information only. It is not medical advice and does not replace care from a qualified clinician.